Q4FY21 Company Update - Abbott India - ICICI Direct

While Q4FY21 results are not directly comparable strictly on a YoY basis due to pandemic related challenges in the base year, FY21 revenues grew 5.3% YoY to Rs. 4310 crore likely moderated by the decline in 'Duphaston' (gynaecology) sales alongside demand slowdown in some other therapies amid the pandemic. EBITDA margins expanded 290 bps YoY to 21.4% with an overall better operational performance. EBITDA for the fiscal grew 21.8% YoY to Rs. 922 crore. PAT was up 16.5% YoY to Rs. 691 crore in line with operational performance and lower other income.

For details, click on the link below: Link to the report

Shares of ABBOTT INDIA LTD. was last trading in BSE at Rs.16051 as compared to the previous close of Rs. 16041.45. The total number of shares traded during the day was 1260 in over 556 trades.

The stock hit an intraday high of Rs. 16104.6 and intraday low of 15900. The net turnover during the day was Rs. 20166045.

Source : Equity Bulls

Keywords